| 2025-11-15 |
复牌提示：
2025-11-14 11:05:19 停牌，复牌日期 2025-11-14 11:10:19
|
| 2025-09-02 |
股东大会：
将于2025-10-14召开股东大会
会议内容 ▼▲
- 1.By an ordinary resolution, to receive and adopt the Directors’ Statement, the audited financial statements of the Company for the financial year ended March 31, 2025;
2.By an ordinary resolution, to receive and adopt the audited financial statements in relation to Form 20-F for the financial year ended March 31, 2025;
3.By ordinary resolutions, to approve the re-election of the following Directors who are retiring by rotation pursuant to Regulation 88 of the Constitution of the Company and who, being eligible, offer themselves for re-election as Directors:
(a)Mr. William Mirecki
(b)Dr. Kai Yue Jason Chan
4.By an ordinary resolution, to approve payment of Directors’ fees of US$215,000 for the financial year ended March 31, 2025.
5.By an ordinary resolution, to approve the appointment of Weinberg & Co. LA, LLP, as auditor of the Company for the financial year ending March 31, 2026 and that the Directors be empowered to fix the auditors’ remuneration in their absolute discretion;
6.By an ordinary resolution, to approve the appointment of M/s Paul Wan & Co, as auditor of the Company for the financial year ending March 31, 2026 and that the Directors be empowered to fix the auditors’ remuneration in their absolute discretion;
7.By an ordinary resolution, to adjourn the Annual General Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal One, Proposal Two, Proposal Three, Proposal Four, Proposal Five and/or Proposal Six.
|
| 2025-07-24 |
详情>>
股本变动：
变动后总股本3841.80万股
变动原因 ▼▲
- 原因：
- From March 31, 2024 to March 31, 2025
Issuance of common shares for services
Issuance of common shares to board of directors
|
| 2025-07-24 |
详情>>
业绩披露：
2025年年报每股收益-0.05美元,归母净利润-194.2万美元,同比去年增长40.04%
|
| 2025-05-13 |
股东大会：
将于2025-06-19召开股东大会
会议内容 ▼▲
- 1.By an ordinary resolution, to resolve that:
A.the incentive plan for the Company and its subsidiaries’ (the “Group”) directors, employees, advisors and consultants, the form of which is set out in Exhibit 99.3 filed as part of this Form 6-K report containing the proxy statement (the “Primech 2025 Employee Incentive Plan”) be approved and adopted;
B.authority be and is hereby given to the board of directors of the Company (the “Directors”) to allot and issue from time to time such number of fully paid-up ordinary shares in the capital of the Company (“Award Shares”) as may be required to be issued pursuant to the grant and/or vesting of awards granted or to be granted under the Primech 2025 Employee Incentive Plan, provided that the aggregate number of Award Shares to be issued, when aggregated with existing shares (including treasury shares) delivered and/or to be delivered pursuant to the Primech 2025 Employee Incentive Plan, shall not exceed fifteen per cent (15%) of the total number of issued ordinary shares in the capital of the Company, as the case may be (excluding treasury shares) from time to time (the “Primech 2025 Employee Incentive Plan Share Issuances”).
2.By a special resolution, to resolve that:
A.authority be and is hereby given for every six (6) issued ordinary shares in the capital of the Company as at a time and date to be determined by the Directors, at and on which the register of members and the transfer books of the Company will be closed for the purpose of determining the entitlements of the shareholders of the Company following the proposed share consolidation (“Share Consolidation Record Date”) be consolidated into one (1) ordinary share of the Company (each a “Consolidated Ordinary Share” and collectively, the “Consolidated Ordinary Shares”) (the “Share Consolidation”), with such Share Consolidation to be effective on such date within 12 months of this resolution as determined by the Directors and such date shall be announced by the Company (the “Effective Date”);
B.all fractional entitlements to the issued Consolidated Ordinary Shares resulting from the Share Consolidation will not be issued to the shareholders of the Company and the Company be authorized to round up any fractional shares resulting from the Share Consolidation such that each shareholder will be entitled to receive one (1) Consolidated Ordinary Share in lieu of any fractional share that would have resulted from the Share Consolidation;
C.any Director be and is hereby authorized to take such steps, enter into all such transactions, arrangements and agreements and execute all such documents as may be advisable, necessary or expedient for the purposes of giving effect to the Share Consolidation, with full power to assent to any condition, amendment, alteration, modification or variation as may be required by the relevant authorities or as such Directors or any of them may deem fit or expedient or to give effect to this special resolution.
3.By an ordinary resolution, to resolve that:
A.authority be and is hereby given, for the purposes of Section 76E of the Singapore Companies Act 1967 (the “Singapore Companies Act”), the exercise by the Directors of all the powers of the Company to purchase or otherwise acquire issued ordinary shares in the capital of the Company (the “Shares”) not exceeding in aggregate the Maximum Limit (as hereinafter defined), at such price(s) as may be determined by the Directors from time to time up to the Maximum Price (as hereinafter defined) by way of an on-market purchase (“Market Acquisition”) transacted on the Nasdaq Capital Market (“Nasdaq”) as may be determined or formulated by the Directors as they consider fit, and shall satisfy all the conditions prescribed by the Singapore Companies Act, and otherwise in accordance with all other laws, regulations and listing rules of Nasdaq (the “Nasdaq Listing Rules”) as may for the time being be applicable, be and is hereby authorized and approved generally and unconditionally (“Share Buyback Mandate”);
B.any Share that is purchased or otherwise acquired by the Company pursuant to the Share Buyback Mandate may be held in treasury and dealt with in accordance with the Singapore Companies Act or cancelled;
C.unless varied or revoked by the Company in general meeting, the authority conferred on the Directors pursuant to the Share Buyback Mandate may be exercised by the Directors at any time and from time to time during the period commencing from the date of the passing of this ordinary resolution and expiring on the earliest of:
(i)the date on which the next annual general meeting of the Company is held or required by law to be held, whichever is earlier;
(ii)the date on which the acquisitions of Shares pursuant to the Share Buyback Mandate are carried out to the full extent mandated;
D.subject to the opinion of the Directors that the Company is solvent and remains solvent subsequent to the Market Acquisition, the purchase price of the acquisitions of Shares pursuant to the Share Buyback Mandate may be paid out of the capital or profit of the Company;
E.in this ordinary resolution:
(i)“Maximum Limit” means 20% of the issued Shares (excluding treasury shares and subsidiary holdings) as at the date of the passing of this ordinary resolution;
(ii)“Maximum Price” in relation to a Share to be purchased, means an amount (excluding brokerage, commission, stamp duty, applicable goods and services tax, clearance fees and other related expenses) which may be paid for a Share purchased or acquired by the Company pursuant to the Share Buyback Mandate, not exceeding the highest independent bid or the last independent transaction price, whichever is higher, of the Shares quoted or reported on Nasdaq, as the case may be, or shall not exceed any volume weighted average price, or other price determined under any pricing mechanism, in compliance with the requirements under Rule 10b-18 under the Exchange Act, at the time the purchase is effected. In addition, if the Company is relying on the bid to support a higher price, at least two independent bids are required.
F.the Directors and/or any of them be and are hereby authorized to complete and do all such acts and things (including executing such documents as may be required) as they and/or he may consider desirable, expedient or necessary to give effect to the transactions contemplated and/or authorized by this ordinary resolution.
4.By an ordinary resolution, to adjourn the Extraordinary General Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal One, and/or Proposal Two and/or Proposal Three.
|
| 2025-03-27 |
详情>>
业绩披露：
2025年中报每股收益-0.03美元,归母净利润-118.7万美元,同比去年增长-630.34%
|
| 2024-07-26 |
股东大会：
将于2024-08-19召开股东大会
会议内容 ▼▲
- 1.By an ordinary resolution, to receive and adopt the Directors’ Statement, the audited financial statements of the Company for the financial year ended March 31, 2024.
2.By an ordinary resolution, to receive and adopt the audited financial statements in relation to Form 20-F for the financial year ended March 31, 2024.
3.By ordinary resolutions, to approve the re-election of the following Directors who are retiring by rotation pursuant to Regulation 88 of the Constitution of the Company and who, being eligible, offer themselves for re-election as Directors.
4.By an ordinary resolution, to approve payment of Directors’ fees of US$77,500 for the financial year ended March 31, 2024.
5.By an ordinary resolution, to approve the appointment of Weinberg & Co. LA, LLP, as auditor of the Company for the financial year ending March 31, 2025 and that the Directors be empowered to fix the auditors’ remuneration in their absolute discretion.
6.By an ordinary resolution, to approve the appointment of M/s Paul Wan & Co, as auditor of the Company for the financial year ending March 31, 2025 and that the Directors be empowered to fix the auditors’ remuneration in their absolute discretion.
7.By an ordinary resolution, to adjourn the Annual General Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal One, Proposal Two, Proposal Three, Proposal Four, Proposal Five and/or Proposal Six.
8.By an ordinary resolution, to resolve that:Pursuant to Section 161 of the Singapore Companies Act 1967 (the “Singapore Companies Act”) the Directors be and are hereby authorized to issue such number of new ordinary shares in the capital of the Company as may be approved by the board of Directors (the “Board”), such shares to rank pari passu in all respects with the existing issued ordinary shares in the capital of the Company in connection with the initial public offering of the Company at the price(s) to be determined by the Board and on such terms and conditions as the Board may at any time and from time to time think fit and allot the same to such members of the public and/or private placees who shall have applied for the shares in connection with the admission of the Company to Nasdaq, as the Board may decide.
|
| 2024-07-23 |
详情>>
业绩披露：
2024年年报每股收益-0.1美元,归母净利润-323.9万美元,同比去年增长-27.93%
|
| 2024-03-28 |
详情>>
业绩披露：
2024年中报每股收益0.01美元,归母净利润22.38万美元,同比去年增长112.20%
|
| 2023-08-18 |
详情>>
业绩披露：
2022年年报每股收益-0.04美元,归母净利润-123.92万美元,同比去年增长-123.11%
|
| 2023-08-18 |
详情>>
业绩披露：
2023年年报每股收益-0.08美元,归母净利润-253.19万美元,同比去年增长-104.32%
|
| 2023-01-31 |
详情>>
业绩披露：
2023年中报每股收益-0.06美元,归母净利润-183.46万美元,同比去年增长-566.81%
|
| 2023-01-31 |
详情>>
业绩披露：
2022年中报每股收益0.01美元,归母净利润39.30万美元,同比去年增长-91.89%
|
| 2023-01-31 |
详情>>
业绩披露：
2021年年报每股收益0.17美元,归母净利润536.31万美元,同比去年增长1631.34%
|